REGULATED PRESS RELEASE published on 08/08/2024 at 18:23, 3 months 13 days ago Disclosure of transactions in own shares on August 5 to August 8, 2024
BRIEF published on 08/07/2024 at 17:40, 3 months 14 days ago Disclosure of the Number of Shares and Voting Rights as of July 31, 2024 Voting Rights Shares EURAZEO Financial Disclosure Capital Structure
REGULATED PRESS RELEASE published on 08/07/2024 at 17:35, 3 months 14 days ago Disclosure of the number of shares and the total number of voting rights as of July 31, 2024 Disclosure of total shares and voting rights by Eurazeo on July 31, 2024. Eurazeo is a leading European investment group managing diversified assets worth 35.0 billion euros Voting Rights Shares EURAZEO Investment Group Financial Disclosure
REGULATED PRESS RELEASE published on 08/05/2024 at 17:35, 3 months 16 days ago Disclosure of transactions in own shares on August 1 to August 2, 2024
REGULATED PRESS RELEASE published on 08/01/2024 at 17:35, 3 months 20 days ago Disclosure of transactions in own shares on July 29 to July 31, 2024
BRIEF published on 07/31/2024 at 18:05, 3 months 21 days ago Completion of the Eres Group Acquisition Acquisition EURAZEO Investment Employee Savings Eres Group
REGULATED PRESS RELEASE published on 07/31/2024 at 18:00, 3 months 21 days ago COMPLETION OF THE ERES GROUP ACQUISITION Eurazeo and co-investors complete €350 million acquisition of Eres Group, a French leader in employee savings plans. Strategic investment for ECV fund Acquisition EURAZEO Eres Group Employee Savings Plans ECV Fund
REGULATED PRESS RELEASE published on 07/29/2024 at 17:35, 3 months 23 days ago Disclosure of transactions in own shares on July 22 to July 26, 2024
BRIEF published on 07/25/2024 at 07:05, 3 months 27 days ago Eurazeo Reports Robust Strategic Execution and Strong H1 2024 Results Asset Management Realizations H1 2024 Results ESG Leadership Impact Funds
REGULATED PRESS RELEASE published on 07/25/2024 at 07:00, 3 months 27 days ago GOOD EXECUTION OF STRATEGIC PLAN: DYNAMIC ASSET MANAGEMENT GROWTH AND PICK-UP IN REALIZATIONS IN H1 2024 Eurazeo shows strong asset management growth and pick-up in realizations in H1 2024, confirming successful execution of strategic plan. Third-party fundraising and management fees up, realizations surge threefold EURAZEO Asset Management Fundraising ESG Realizations
Published on 11/21/2024 at 22:05, 38 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 53 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 2 hours 28 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 2 hours 33 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 2 hours 43 minutes ago Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Published on 11/21/2024 at 19:01, 3 hours 41 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 4 hours 6 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 4 hours 44 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 4 hours 51 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 4 hours 51 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 15 hours 45 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 3 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 4 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 4 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 14 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo